CMPX 8-K: SEC filing

Compass Therapeutics, Inc.

Filed with the SEC on Nov 9, 2026 · accession 0001171843-26-007256

CMPX filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Compass Therapeutics, Inc. issued a press release announcing its financial results for the quarter and nine months ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantCompass Therapeutics, Inc.

Chief accounting officerNeil Lerner

✦ Ask GOAX AI about this filing — what it means for CMPX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CMPX?

Click here

Frequently asked questions

What did CMPX file with the SEC on Nov 9, 2026?

CMPX filed a 8-K (SEC filing). Compass Therapeutics, Inc. issued a press release announcing its financial results for the quarter and nine months ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other CMPX SEC filings

Get alerts when CMPX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

CMPX overview CMPX analysis CMPX news Latest SEC filings